In order to cut prices of patented medicines for cancer and rare diseases, a government panel in India has made a series of recommendations including granting "compulsory licenses" to any domestic pharmaceutical company to produce drugs without the consen
In order to cut prices of patented medicines for cancer and rare diseases, a government panel in India has made a series of recommendations including granting "compulsory licenses" to any domestic pharmaceutical company to produce drugs without the consen